Erratum for the Clinical and Translational Medicine ‘LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c‐Myc mRNA stability’ by Yiran Zhu et al.
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-11-01
|
| Series: | Clinical and Translational Medicine |
| Online Access: | https://doi.org/10.1002/ctm2.70106 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850177595148075008 |
|---|---|
| author | Yiran Zhu Bingluo Zhou Xinyang Hu Shilong Ying Qiyin Zhou Wenxia Xu Lifeng Feng Tianlun Hou Xian Wang Liyuan Zhu Hongchuan Jin |
| author_facet | Yiran Zhu Bingluo Zhou Xinyang Hu Shilong Ying Qiyin Zhou Wenxia Xu Lifeng Feng Tianlun Hou Xian Wang Liyuan Zhu Hongchuan Jin |
| author_sort | Yiran Zhu |
| collection | DOAJ |
| format | Article |
| id | doaj-art-8a66c83a291042ed87aae41ff2438ae2 |
| institution | OA Journals |
| issn | 2001-1326 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical and Translational Medicine |
| spelling | doaj-art-8a66c83a291042ed87aae41ff2438ae22025-08-20T02:18:57ZengWileyClinical and Translational Medicine2001-13262024-11-011411n/an/a10.1002/ctm2.70106Erratum for the Clinical and Translational Medicine ‘LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c‐Myc mRNA stability’ by Yiran Zhu et al.Yiran Zhu0Bingluo Zhou1Xinyang Hu2Shilong Ying3Qiyin Zhou4Wenxia Xu5Lifeng Feng6Tianlun Hou7Xian Wang8Liyuan Zhu9Hongchuan Jin10Laboratory of Cancer Biology Key Lab of Biotherapy in Zhejiang Province, Cancer Center of Zhejiang University Sir Run Run Shaw Hospital School of Medicine, Zhejiang University Hangzhou Zhejiang ChinaLaboratory of Cancer Biology Key Lab of Biotherapy in Zhejiang Province, Cancer Center of Zhejiang University Sir Run Run Shaw Hospital School of Medicine, Zhejiang University Hangzhou Zhejiang ChinaLaboratory of Cancer Biology Key Lab of Biotherapy in Zhejiang Province, Cancer Center of Zhejiang University Sir Run Run Shaw Hospital School of Medicine, Zhejiang University Hangzhou Zhejiang ChinaLaboratory of Cancer Biology Key Lab of Biotherapy in Zhejiang Province, Cancer Center of Zhejiang University Sir Run Run Shaw Hospital School of Medicine, Zhejiang University Hangzhou Zhejiang ChinaDepartment of Medical Oncology, Sir Run Run Shaw Hospital, School of Medicine Zhejiang University Hangzhou Zhejiang ChinaLaboratory of Cancer Biology Key Lab of Biotherapy in Zhejiang Province, Cancer Center of Zhejiang University Sir Run Run Shaw Hospital School of Medicine, Zhejiang University Hangzhou Zhejiang ChinaLaboratory of Cancer Biology Key Lab of Biotherapy in Zhejiang Province, Cancer Center of Zhejiang University Sir Run Run Shaw Hospital School of Medicine, Zhejiang University Hangzhou Zhejiang ChinaDepartment of Clinical Medicine Wenzhou Medical University Wenzhou Zhejiang ChinaDepartment of Medical Oncology, Sir Run Run Shaw Hospital, School of Medicine Zhejiang University Hangzhou Zhejiang ChinaLaboratory of Cancer Biology Key Lab of Biotherapy in Zhejiang Province, Cancer Center of Zhejiang University Sir Run Run Shaw Hospital School of Medicine, Zhejiang University Hangzhou Zhejiang ChinaLaboratory of Cancer Biology Key Lab of Biotherapy in Zhejiang Province, Cancer Center of Zhejiang University Sir Run Run Shaw Hospital School of Medicine, Zhejiang University Hangzhou Zhejiang Chinahttps://doi.org/10.1002/ctm2.70106 |
| spellingShingle | Yiran Zhu Bingluo Zhou Xinyang Hu Shilong Ying Qiyin Zhou Wenxia Xu Lifeng Feng Tianlun Hou Xian Wang Liyuan Zhu Hongchuan Jin Erratum for the Clinical and Translational Medicine ‘LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c‐Myc mRNA stability’ by Yiran Zhu et al. Clinical and Translational Medicine |
| title | Erratum for the Clinical and Translational Medicine ‘LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c‐Myc mRNA stability’ by Yiran Zhu et al. |
| title_full | Erratum for the Clinical and Translational Medicine ‘LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c‐Myc mRNA stability’ by Yiran Zhu et al. |
| title_fullStr | Erratum for the Clinical and Translational Medicine ‘LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c‐Myc mRNA stability’ by Yiran Zhu et al. |
| title_full_unstemmed | Erratum for the Clinical and Translational Medicine ‘LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c‐Myc mRNA stability’ by Yiran Zhu et al. |
| title_short | Erratum for the Clinical and Translational Medicine ‘LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c‐Myc mRNA stability’ by Yiran Zhu et al. |
| title_sort | erratum for the clinical and translational medicine lncrna linc00942 promotes chemoresistance in gastric cancer by suppressing msi2 degradation to enhance c myc mrna stability by yiran zhu et al |
| url | https://doi.org/10.1002/ctm2.70106 |
| work_keys_str_mv | AT yiranzhu erratumfortheclinicalandtranslationalmedicinelncrnalinc00942promoteschemoresistanceingastriccancerbysuppressingmsi2degradationtoenhancecmycmrnastabilitybyyiranzhuetal AT bingluozhou erratumfortheclinicalandtranslationalmedicinelncrnalinc00942promoteschemoresistanceingastriccancerbysuppressingmsi2degradationtoenhancecmycmrnastabilitybyyiranzhuetal AT xinyanghu erratumfortheclinicalandtranslationalmedicinelncrnalinc00942promoteschemoresistanceingastriccancerbysuppressingmsi2degradationtoenhancecmycmrnastabilitybyyiranzhuetal AT shilongying erratumfortheclinicalandtranslationalmedicinelncrnalinc00942promoteschemoresistanceingastriccancerbysuppressingmsi2degradationtoenhancecmycmrnastabilitybyyiranzhuetal AT qiyinzhou erratumfortheclinicalandtranslationalmedicinelncrnalinc00942promoteschemoresistanceingastriccancerbysuppressingmsi2degradationtoenhancecmycmrnastabilitybyyiranzhuetal AT wenxiaxu erratumfortheclinicalandtranslationalmedicinelncrnalinc00942promoteschemoresistanceingastriccancerbysuppressingmsi2degradationtoenhancecmycmrnastabilitybyyiranzhuetal AT lifengfeng erratumfortheclinicalandtranslationalmedicinelncrnalinc00942promoteschemoresistanceingastriccancerbysuppressingmsi2degradationtoenhancecmycmrnastabilitybyyiranzhuetal AT tianlunhou erratumfortheclinicalandtranslationalmedicinelncrnalinc00942promoteschemoresistanceingastriccancerbysuppressingmsi2degradationtoenhancecmycmrnastabilitybyyiranzhuetal AT xianwang erratumfortheclinicalandtranslationalmedicinelncrnalinc00942promoteschemoresistanceingastriccancerbysuppressingmsi2degradationtoenhancecmycmrnastabilitybyyiranzhuetal AT liyuanzhu erratumfortheclinicalandtranslationalmedicinelncrnalinc00942promoteschemoresistanceingastriccancerbysuppressingmsi2degradationtoenhancecmycmrnastabilitybyyiranzhuetal AT hongchuanjin erratumfortheclinicalandtranslationalmedicinelncrnalinc00942promoteschemoresistanceingastriccancerbysuppressingmsi2degradationtoenhancecmycmrnastabilitybyyiranzhuetal |